KOPP INVESTMENT ADVISORS LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 208 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
KOPP INVESTMENT ADVISORS LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$1,359,000
-46.9%
49,462
-36.1%
2.50%
-14.4%
Q2 2019$2,561,000
-26.9%
77,392
-22.6%
2.92%
+3.0%
Q1 2019$3,503,000
+38.8%
99,975
+31.6%
2.83%
+15.2%
Q4 2018$2,523,000
+20.1%
75,962
+82.2%
2.46%
+39.3%
Q3 2018$2,100,000
-16.2%
41,700
-0.4%
1.77%
-24.8%
Q2 2018$2,506,000
+47.9%
41,879
+13.3%
2.35%
+36.5%
Q1 2018$1,694,000
-3.6%
36,976
-16.2%
1.72%
-2.2%
Q4 2017$1,758,000
-4.1%
44,121
-3.7%
1.76%
+4.8%
Q3 2017$1,833,000
-7.1%
45,831
+0.1%
1.68%
-4.9%
Q2 2017$1,973,000
+35.4%
45,782
-1.7%
1.77%
+24.0%
Q1 2017$1,457,000
+25.5%
46,555
+1.2%
1.42%
+16.2%
Q4 2016$1,161,000
+0.3%
45,989
-1.8%
1.23%
+7.2%
Q3 2016$1,158,000
+18.8%
46,839
-2.2%
1.14%
+120.4%
Q2 2016$975,000
-90.5%
47,884
-93.4%
0.52%
-90.6%
Q3 2015$10,241,000
-32.3%
729,960
-18.0%
5.51%
-18.2%
Q2 2015$15,124,000
+103.9%
890,705
+45.2%
6.74%
+105.2%
Q1 2015$7,418,000
+47.7%
613,590
+1.4%
3.28%
+35.9%
Q4 2014$5,024,000
-19.8%
605,245
-16.1%
2.42%
-22.1%
Q3 2014$6,266,000
-13.9%
721,065
+8.5%
3.10%
-7.3%
Q2 2014$7,276,000
+390.6%
664,470
+300.7%
3.34%
+437.5%
Q1 2014$1,483,000165,8300.62%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders